0001104659-18-055820.txt : 20180907
0001104659-18-055820.hdr.sgml : 20180907
20180907170036
ACCESSION NUMBER: 0001104659-18-055820
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180823
FILED AS OF DATE: 20180907
DATE AS OF CHANGE: 20180907
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fricker William
CENTRAL INDEX KEY: 0001752213
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-12104
FILM NUMBER: 181060700
MAIL ADDRESS:
STREET 1: 300 THE AMERICAN ROAD
CITY: MORRIS PLAINS
STATE: NJ
ZIP: 07950
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IMMUNOMEDICS INC
CENTRAL INDEX KEY: 0000722830
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 611009366
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 300 AMERICAN RD
CITY: MORRIS PLAINS
STATE: NJ
ZIP: 07950
BUSINESS PHONE: 9736058200
MAIL ADDRESS:
STREET 1: 300 AMERICAN ROAD
CITY: MORRIS PLAINS
STATE: NJ
ZIP: 07950
3
1
a3.xml
3
X0206
3
2018-08-23
0
0000722830
IMMUNOMEDICS INC
IMMU
0001752213
Fricker William
C/O IMMUNOMEDICS
300 THE AMERICAN ROAD
MORRIS PLAINS
NJ
07950
0
1
0
0
See Remarks
Stock Options (right to buy)
16.66
2019-02-01
2025-02-01
Common stock, $0.01 par value per share
15000
D
The reporting person was granted stock options pursuant to the Company's 2014 Long-Term Incentive Plan. The stock options vest 25% on the first anniversary of the date of grant and 25% on a annual basis thereafter.
On August 23, 2018, the Company appointed Mr. William Fricker, the Company's Executive Director and Corporate Controller, to serve as the Company's principal accounting officer.
/s/ William Fricker
2018-09-07